Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status.
Cancers (Basel)
; 15(18)2023 Sep 09.
Article
in En
| MEDLINE
| ID: mdl-37760461
ABSTRACT
(1)